ROEN Surgical
South Korean surgical robotics company founded in 2018 from KAIST research, developing Zamenix — the world's first AI-based robotic kidney stone surgery system.
ROEN Surgical Inc. was founded in 2018 in Daejeon, South Korea, based on over 25 years of robotics research from the Korea Advanced Institute of Science and Technology (KAIST). The company specializes in flexible surgical robotics for endoluminal procedures, targeting urology, gastroenterology, and gynecology. Its flagship product, Zamenix, is the world's first AI-powered fully robotic kidney stone surgery system.
Zamenix employs a 2.8 mm flexible endoscope to remove kidney stones through the body's natural orifices without open incision, and includes automation features for stable, precise robotic control during flexible ureteroscopy. Zamenix was designated as South Korea's 17th Innovative Medical Device by the Ministry of Food and Drug Safety in 2021 and recognized as Innovative Medical Technology by the Ministry of Health and Welfare in 2023. The company has conducted international clinical demonstrations in Thailand and Indonesia, advancing its global commercialization strategy.
Primary type & automation activities this supplier delivers:
Zamenix Robotic Ureteroscopy System
AI-powered robotic flexible ureteroscopy system for kidney stone removal without incision, using a 2.8mm flexible endoscope.
Contact ROEN Surgical
WEBSITE
https://roensurgical.comPHONE
+82-42-867-1220HEADQUARTERS
Korea, Republic of (South)
Company Facts
Founded
2018
Primary Role
Manufacturer
Company Size
-
Primary Region
Asia-Pacific
Annual Sales
-
Funding Stage
-
Funding Total
-
